More Stories

Edoxaban in venous thromboembolism: Clinical considerations

Edoxaban (Marketed as Savaysa, Daiichi Sankyo, Tokyo), an oral, once-daily factor Xa inhibitor, was approved...

Zilver PTX Japan PMS

Dr. Jaff: Welcome to VIVA 365. I am Michael Jaff. I am joined by Gary...

Sole Pedal Access as primary approach in invasive management of PAD

Peripheral arterial disease is a prevalent disease affecting 8 million Americans and is associated with...

What is the best treatment for this acute limb ischemia patient?

This issue is complex but approached in a systematic way most patients declare themselves better...

Roadster Trial

Welcome to VIVA 365. I am Dr. Michael Jaff, joined by a panel of experts:...

What Happens to Patients Who Suffer Pulmonary Embolus

Pulmonary embolism (PE) is a common and often fatal disease process whose clinical presentation and...

Fenestrated and Branched Stent Grafts are Best for Arch Aneurysms

Aortic arch aneurysms present a significant clinical challenge. Despite improvements in operative techniques and peri-operative...

Pulmonary Embolism Response Team

The problem: There is much uncertainty in the management of pulmonary embolism Acute pulmonary embolism...

Multi-modality Approach for Chronic In-stent Thrombosis: A Case Presentation

A 63 year old male presents with Rutherford class III claudication symptoms on the left...

Approach to Patients with Acute Limb Ischemia

The assessment and management of acute limb ischemia begins with a thorough history and physical...